PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Simcere Pharmaceutical Group Ltd (2096.HK)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINHK0000658531
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Highlights

Market CapHK$17.72B
Year RangeHK$4.79 - HK$7.64
Target PriceHK$8.98

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of HK$10,000 in Simcere Pharmaceutical Group Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%10.00%20.00%30.00%40.00%MayJuneJulyAugustSeptemberOctober
39.80%
8.64%
2096.HK (Simcere Pharmaceutical Group Ltd)
Benchmark (^GSPC)

Returns By Period

Simcere Pharmaceutical Group Ltd had a return of 9.47% year-to-date (YTD) and 20.78% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date9.47%19.70%
1 month22.22%1.08%
6 months39.80%9.56%
1 year20.78%34.99%
5 years (annualized)N/A14.15%
10 years (annualized)N/A11.26%

Monthly Returns

The table below presents the monthly returns of 2096.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-22.74%7.12%-4.67%1.69%8.52%0.76%-6.28%10.06%15.74%9.47%
2023-6.71%-5.90%-19.12%12.12%-17.95%4.62%-5.15%-16.98%4.75%6.56%8.21%-8.81%-40.73%
2022-14.68%23.21%11.96%-20.04%10.76%-6.50%-3.49%-5.30%-13.36%28.05%17.43%13.48%31.67%
2021-5.92%-3.80%1.48%-0.24%31.46%31.42%-30.19%-20.08%-12.56%19.06%14.53%-3.33%1.79%
2020-2.73%-23.69%9.82%-18.49%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of 2096.HK is 52, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of 2096.HK is 5252
2096.HK (Simcere Pharmaceutical Group Ltd)
The Sharpe Ratio Rank of 2096.HK is 5858Sharpe Ratio Rank
The Sortino Ratio Rank of 2096.HK is 5252Sortino Ratio Rank
The Omega Ratio Rank of 2096.HK is 4949Omega Ratio Rank
The Calmar Ratio Rank of 2096.HK is 5454Calmar Ratio Rank
The Martin Ratio Rank of 2096.HK is 4949Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Simcere Pharmaceutical Group Ltd (2096.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


2096.HK
Sharpe ratio
The chart of Sharpe ratio for 2096.HK, currently valued at 0.49, compared to the broader market-4.00-2.000.002.000.49
Sortino ratio
The chart of Sortino ratio for 2096.HK, currently valued at 0.95, compared to the broader market-4.00-2.000.002.004.000.95
Omega ratio
The chart of Omega ratio for 2096.HK, currently valued at 1.11, compared to the broader market0.501.001.501.11
Calmar ratio
The chart of Calmar ratio for 2096.HK, currently valued at 0.27, compared to the broader market0.002.004.006.000.27
Martin ratio
The chart of Martin ratio for 2096.HK, currently valued at 0.75, compared to the broader market-10.000.0010.0020.000.75
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.64, compared to the broader market-4.00-2.000.002.002.64
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.52, compared to the broader market-4.00-2.000.002.004.003.52
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.48, compared to the broader market0.501.001.501.48
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 2.34, compared to the broader market0.002.004.006.002.34
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 16.17, compared to the broader market-10.000.0010.0020.0016.17

Sharpe Ratio

The current Simcere Pharmaceutical Group Ltd Sharpe ratio is 0.49. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Simcere Pharmaceutical Group Ltd with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00MayJuneJulyAugustSeptemberOctober
0.49
2.54
2096.HK (Simcere Pharmaceutical Group Ltd)
Benchmark (^GSPC)

Dividends

Dividend History

Simcere Pharmaceutical Group Ltd granted a 2.46% dividend yield in the last twelve months. The annual payout for that period amounted to HK$0.18 per share.


PeriodTTM202320222021
DividendHK$0.18HK$0.18HK$0.18HK$0.18

Dividend yield

2.46%2.61%1.51%2.01%

Monthly Dividends

The table displays the monthly dividend distributions for Simcere Pharmaceutical Group Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.18HK$0.00HK$0.00HK$0.00HK$0.00HK$0.18
2023HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.18HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.18
2022HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.18HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.18
2021HK$0.18HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.18

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%2.5%
Simcere Pharmaceutical Group Ltd has a dividend yield of 2.46%, which is quite average when compared to the overall market.
Payout Ratio
200.0%400.0%600.0%800.0%60.2%
Simcere Pharmaceutical Group Ltd has a payout ratio of 60.24%, which is quite average when compared to the overall market. This suggests that Simcere Pharmaceutical Group Ltd strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%MayJuneJulyAugustSeptemberOctober
-45.06%
-1.04%
2096.HK (Simcere Pharmaceutical Group Ltd)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Simcere Pharmaceutical Group Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Simcere Pharmaceutical Group Ltd was 62.49%, occurring on Feb 5, 2024. The portfolio has not yet recovered.

The current Simcere Pharmaceutical Group Ltd drawdown is 45.06%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-62.49%Jul 2, 2021640Feb 5, 2024
-33.13%Oct 30, 2020131May 11, 202119Jun 8, 2021150
-6.79%Jun 16, 20211Jun 16, 20217Jun 25, 20218
-1.34%Jun 29, 20211Jun 29, 20211Jun 30, 20212

Volatility

Volatility Chart

The current Simcere Pharmaceutical Group Ltd volatility is 9.34%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%MayJuneJulyAugustSeptemberOctober
9.34%
3.37%
2096.HK (Simcere Pharmaceutical Group Ltd)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Simcere Pharmaceutical Group Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Simcere Pharmaceutical Group Ltd.


Loading data...

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items